Global Transplant Diagnostics Market Report (2018-2023) -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
117
Global Transplant Diagnostics Market Report (2018-2023) - The Molecular Assay Technology Segment is Expected to Account for the Largest Share of the Market

Dublin, July 12, 2018 (GLOBE NEWSWIRE) -- The "Transplant Diagnostics Market by Technology, Product, Application, Type, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%.

Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, the high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.

This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products. Based on product & service, the market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the market in 2018. Growing adoption of transplant diagnostic techniques in related research studies and rising number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables. On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to augment organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation. Based on application, the market is categorized into diagnostic and research applications. The diagnostic applications segment accounted for the largest share of the market in 2018. The rising incidence of chronic diseases (that often lead to transplantation in critical and terminal patients) and greater risk of genetic disorders and pathogenic infections after transplantation (due to weaker immunity in geriatric recipients and discovery of novel biomarkers to identify genetic disorders) are the key factors supporting the growth of the transplant diagnostics market for diagnostic applications. Based on end user, the market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching, growing number of organ transplantation procedures, and growing inauguration & accreditation of diagnostic laboratories across emerging as well as developed countries. This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.

Key Topics Covered

1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Geographic Scope 1.3.3 Years Considered for the Study 1.4 Currency Used for the Study 1.5 Major Market Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.2 Primary Data 2.2 Market Size Estimation 2.2.1 Product-Based Market Estimation 2.2.2 Procedure Based Market Estimation 2.2.3 Primary Research Validation 2.3 Data Triangulation 2.4 Research Assumptions 2.5 Research Limitations 3 Executive Summary 4 Premium Insights 4.1 Transplant Diagnostics Market Overview 4.2 Market, By Technology 4.3 Regional Analysis: Market, By Application 4.4 Asia Pacific: Market, By End User, 2018 4.5 Regional Analysis: Market, By Product & Service 4.6 Regional Analysis: Market, By Transplant Type 4.7 Transplant Diagnostics Market, By Country 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Key Market Drivers 5.2.1.1 Increasing Number of Transplant Procedures 5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics 5.2.1.3 Increasing Public-Private Funding for Target Research Activities 5.2.1.4 Growing Burden of Infectious Diseases 5.2.2 Key Market Restraints 5.2.2.1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays 5.2.2.2 Limited Reimbursements for Target Procedures 5.2.3 Key Market Opportunities 5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation 5.2.3.2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries 5.2.4 Key Market Challenges 5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually 5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening 6 Transplant Diagnostics Market, By Product and Services 6.1 Introduction 6.2 Reagents and Consumables 6.3 Instruments 6.4 Software and Services 7 Transplant Diagnostics Market, By Technology 7.1 Introduction 7.2 Molecular Assays 7.2.1 PCR-Based Molecular Assays 7.2.1.1 Real-Time PCR 7.2.1.2 Sequence-Specific Primer-PCR 7.2.1.3 Sequence-Specific Oligonucleotide-PCR 7.2.1.4 Other PCR-Based Molecular Assays 7.2.2 Sequencing-Based Molecular Assays 7.2.2.1 Sanger Sequencing 7.2.2.2 Next-Generation Sequencing 7.2.2.3 Other Sequencing Molecular Assays 7.3 Non-Molecular Assays 8 Transplant Diagnostics Market, By Transplant Type 8.1 Introduction 8.2 Solid Organ Transplantation 8.2.1 Kidney Transplantation 8.2.2 Liver Transplantation 8.2.3 Heart Transplantation 8.2.4 Lung Transplantation 8.2.5 Pancreas Transplantation 8.2.6 Other Organ Transplantations 8.3 Stem Cell Transplantation 8.4 Soft Tissue Transplantation 9 Transplant Diagnostics Market, By Application 9.1 Introduction 9.2 Diagnostic Applications 9.2.1 Pre-Transplantation Diagnostics 9.2.1.1 Infectious Disease Testing 9.2.1.2 Histocompatibility Testing 9.2.1.3 Blood Profiling 9.2.2 Post-Transplantation Diagnostics 9.3 Research Applications 10 Transplant Diagnostics Market, By End User 10.1 Introduction 10.2 Independent Reference Laboratories 10.3 Hospitals & Transplant Centers 10.4 Research Laboratories & Academic Institutes 11 Transplant Diagnostics Market, By Region 11.1 Introduction 11.2 North America 11.2.1 US 11.2.2 Canada 11.3 Europe 11.3.1 Germany 11.3.2 UK 11.3.3 France 11.3.4 Rest of Europe 11.4 Asia Pacific 11.4.1 Japan 11.4.2 China 11.4.3 India 11.4.4 Rest of Asia Pacific 11.5 Rest of the World 12 Competitive Landscape 12.1 Overview 12.2 Market Share Analysis 12.3 Competitive Scenario 12.3.1 Key Product Launches and Enhancements (2014 to 2018) 12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018) 12.3.3 Major Acquisitions (2014 to 2018) 12.3.4 Key Expansions (2014 to 2018) 13 Company Profiles 13.1 Introduction 13.2 Becton, Dickinson and Company 13.3 Biofortuna 13.4 Biomrieux SA 13.5 Bio-Rad Laboratories 13.6 Caredx 13.7 F. Hoffman-La Roche Limited 13.8 Gendx 13.9 Hologic 13.10 Illumina 13.11 Immucor 13.12 Luminex 13.13 Merck KGaA 13.14 Omixon 13.15 Qiagen 13.16 Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/8...plant?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Diagnostics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 105

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Sophia Space Tests the Software Layer for Orbit Ahead

Updated Category News Views 37

Orbit got a little less theoretical when Sophia Space put its operating system across multiple Kepler Communications satellites. That is not a finished orbital data center, despite the inevitable big-language parade around this sort of announcement. It is a software deployment, a real one, aboard Kepler's Tranche 1 optical data relay constellation. In an industry stuffed...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 62

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 112

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
iFLYTEK’s AINOTE Discounts Put E-Ink Utility on Trial

Updated Category News Views 6

A slim E-Ink notebook is getting shoved into the Black Friday brawl, and iFLYTEK is betting that less screen glare and more follow-through can still command a serious price. The company has put discounts of up to 25% on its AINOTE lineup, a sensible move in a gadget season where buyers have no shortage of tablets, voice apps, and half-used productivity subscriptions...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 61

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 167

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 77

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
California Budget Warning Puts Reserves Back in Focus

Updated Category News Views 28

California’s rainy-day umbrella is getting another hard look, and it should. State Controller Malia M. Cohen is pointing to the Legislative Analyst’s Office fiscal outlook as a reminder that budget discipline and stronger reserves are not ornamental good-government phrases. They are the difference between absorbing a revenue wobble and reaching for ugly fixes after...

Continue Reading
OCEG Faces China's Demographic Test After 40 Years

Updated Category News Views 83

A school group that once opened 35 kindergartens in a year is admitting the old playbook has run its course. That is the real message behind Oriental Cambridge Education Group's 40th-anniversary talk, not the balloons and ceremonial language. OCEG operates more than 170 institutions across 39 Chinese cities, and its chairman, Yu Yue, says the next chapter will be judged...

Continue Reading

Top 5 Most Recently Viewed Articles

Radius Insights Launches New Technology Research Practice

Updated Category News Views 131

Radius Insights Launches Radius Tech A focused expansion of Radius' technology expertise aims to help tech brands make smarter, faster growth decisions. Radius Insights recently unveiled the launch of Radius Tech, a dedicated technology division within Radius designed to deliver precise market research and customer insights specifically tailored for technology companies....

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 176

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Gaxos.ai to Skyrocket Connections at Unite 2024 Conference

Updated Category News Views 71

Gaxos.ai's Involvement at Unite 2024 Conference Gaxos.ai Inc. is preparing for a major presence at the Unite 2024 Conference, a vibrant event dedicated to showcasing the latest innovations in gaming and technology. This conference is well-known for bringing together game developers, artists, and tech enthusiasts. Running from September 18 to September 20, Gaxos is eager...

Continue Reading
XNRGY Climate Systems Completes Strategic Growth Financing

Updated Category News Views 365

XNRGY Climate Systems Strengthens Financial Foundation XNRGY Climate Systems, recognized as a key player in sustainable technologies, recently revealed that it has effectively finalized its financing round. This includes a significant investment partnership with Capital Bridge Group and Prologis Ventures. With this move, XNRGY aims to push forward its mission of advancing...

Continue Reading
BioLife Solutions Sells SAVSU to Enhance Logistics Strategy

Updated Category News Views 211

BioLife Solutions Completes Strategic Sale of SAVSU BioLife Solutions, Inc. (Nasdaq: BLFS), a prominent provider of cell processing tools for the cell and gene therapy market, has recently announced a significant event in its operational strategy. The company has sold its wholly owned cold chain logistics subsidiary, SAVSU Cleo Technologies, LLC., previously known as...

Continue Reading